 | Given the vast amount of misinformation presented in the consumer media regarding cosmetic treatments, In The Know presents patients with information grounded in medicine and coming from the real experts. We talk with dermatologists and cosmetic surgeons on topics ranging from rosacea and acne, to fillers, lasers and facelifts. We hope the topics educate patients, inspire them to ask questions, and maybe even spur them to try a procedure.
To read our content, click here. |  |
| | | | Study lets teens talk about acne therapies
Aug 19, 2008
San Francisco — American teens would pay an average of $275 to have never had acne, according to a study, published in the Archives of Dermatology, where researchers surveyed 266 high school students in San Francisco. | | Study: Moisturizers raise skin cancer risk
Aug 14, 2008
New Brunswick, N.J. — Common moisturizers increase the production of tumors in mice that have previously been exposed to UV rays, according to a study published in the Journal of Investigative Dermatology. | | Black henna can cause serious skin reactions
Aug 11, 2008
Chicago — Dermatologists warn consumers that black henna tattoos contain para-phenylenediamine (PPD), a harmful chemical associated with a rash and major skin problems, according to PR Newswire. | | Anti-parasite drug targets cancer-causing protein
Aug 7, 2008
New York — Researchers have found mebendazole, a widely prescribed drug used to treat parasitic infections, to be a a viable investigational agent for the treatment of chemotherapy-resistant malignant melanoma, ScienceDaily reports. | |
|  More Articles |
| | | | | FDA clears Iridex IQ Laser Systems
Aug 18, 2008
Mountain view, Calif. — Iridex Corporation says it has received clearance from the U.S. Food and Drug Administration (FDA) for its IQ Laser Systems, according to BioOptics World. | | Obagi Medical launches SoluCLENZ Rx Gel for the treatment of acne
Aug 13, 2008
Long beach, Calif. — Obagi Medical Products announces the launch of SoluCLENZ Rx Gel,a solubilized benzoyl peroxide, used for the treatment of acne, according to marketwatch. | | Cipher announces U.S. distribution and supply agreement with Ranbaxy for CIP-ISOTRETINOIN
Aug 8, 2008
Mississauga, Ontario — Cipher Pharmaceuticals announces it has entered into a distribution and supply agreement with Ranbaxy Laboratories Limited for Ranbaxy to market, sell and distribute CIP-ISOTRETINOIN in the United States, MarketWatch reports. | | New dermal filler launched
Aug 6, 2008
San Diego — Artes Medical announces the immediate launch and commercial sale of Food and Drug Administration-approved Elevess, a new hyaluronic acid dermal filler formulated with an anesthetic for patient comfort, according to a press release. | |
| | More Articles |
| |
 |  | Athletes are center stage this month, as the eyes of the world turn to the 2008 Summer Olympic Games in Beijing. And athletes constitute a special niche of patients for a dermatology practice, presenting with exacerbations of common skin conditions, damage from environmental insult, and a variety of infections that are linked to — and spread through — contact with teammates and shared use of equipment and facilities. Our special report highlights some of the specific skin concerns of the mighty and muscular.
To read our content, click here. |
| 
Dermatology Times archives are now available on ModernMedicine.com, a new online resource designed to meet the evolving needs of physicians.